IDH1 and glioblastoma: There is, however, a small subset of IDH-wildtype diffuse gliomas that lack the histologic and molecular features of glioblastoma [16] as well as other high grade molecular features (including homozygous CDKN2A loss) that also had incongruously low overall CNV and relatively favorable clinical outcomes [92].